TRPHARM   Report issue

For profit Phase 1
Founded: Istanbul Turkey (2013)

Organization Overview

First Clinical Trial
2016
NCT02667639
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

TRPHARM